|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 5/087 | (2006.01) |
| (11) | Number of the document | 3101026 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16166492.5 |
| Date of filing the European patent application | 2005-08-08 | |
| (97) | Date of publication of the European application | 2016-12-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-28 |
| (46) | Date of publication of the claims translation | 2018-07-10 |
| (30) | Number | Date | Country code |
| 599401 P | 2004-08-06 | US | |
| 610001 P | 2004-09-14 | US | |
| 106879 | 2005-04-14 | US |
| (72) |
SMYTH, Mark S., US
LAIDIG, Guy J., US
|
| (73) |
Onyx Therapeutics, Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Junginiai, skirti proteosomos fermento inhibavimui |
| COMPOUNDS FOR PROTEASOME ENZYME INHIBITION |
| Payment date | Validity (years) | Amount | |
| 2024-07-23 | 347.00 EUR |